merck glp 1 drug GLP-1 medication and its types GLP-1 Medications | Daniel Stark
Description
The GLP1-RAs vs sodium-glucose cotransporter-2 (SGLT-2) inhibitors cohort included new users of GLP-1 RAs (n=83,464) or SGLT-2 inhibitors (n=78,366), and the GLP1-RAs vs dipeptidyl peptidase-4 (DPP-4) inhibitors cohort included new users of GLP-1 RAs (n=108,322) or DPP-4 inhibitors (n=55,411)
Joel Habener, Lotte Bjerre Knudsen, Svetlana Mojsov
What is Retatrutide
These drugs have potent glucose-lowering actions and, additionally, lower body weight through satiety induction while reducing blood pressure and dyslipidemia
While injectable incretin therapies have been transformative, obesity is a chronic
